• Rucaparib (AG-014699): Enhanced Protocols for DNA Repair Res

  2026-07-27

  Rucaparib (AG-014699) empowers precision in DNA repair, radiosensitization, and cancer model workflows, especially where alternative splicing or PTEN/ETS status dictates sensitivity. This guide decodes advanced protocols and troubleshooting strategies, integrating new findings in spliceosome acetylation to maximize research outcomes.

• ISRIB (trans-isomer) as a Precision Tool for Targeting ATF4-

  2026-07-27

  Explore how ISRIB (trans-isomer), a leading PERK inhibitor, enables precise modulation of ATF4-regulated pathways in liver fibrosis and beyond. This article uniquely bridges molecular mechanism with translational research, providing actionable insights for ER stress and apoptosis assays.

• D-Luciferin Potassium Salt: Precision Imaging and Assay Solu

  2026-07-26

  D-Luciferin (potassium salt) empowers researchers with unmatched sensitivity and workflow efficiency for both in vivo bioluminescence imaging and in vitro luciferase assays. Its water solubility and high purity streamline tumor and stem cell tracking, as well as high-throughput screening, making it indispensable for translational research.

• Deferiprone in Translational Research: Iron, Apoptosis, and

  2026-07-25

  This thought-leadership article illuminates how Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one), through precision iron modulation, is advancing the frontiers of translational research in cancer biology, metabolic reprogramming, and neurovascular protection. Integrating mechanistic findings from recent metabolomics studies and validated workflows, we provide strategic guidance for leveraging Deferiprone—sourced from APExBIO—for reproducible control of iron-dependent signaling, apoptosis induction, and experimental resilience.

• HDAC Inhibition Reverses EBV-Induced Plasticity in NPC Cells

  2026-07-24

  This study uncovers how Epstein-Barr virus (EBV) drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma (NPC) through epigenetic repression of CEBPA. It demonstrates that HDAC inhibition can restore differentiation, offering a mechanistic basis for targeting cellular plasticity in solid tumors and informing future differentiation therapy strategies.

• DIDS: Advanced Assay Design and Translational Insights in Ch

  2026-07-24

  Explore the multifaceted role of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) in channel modulation, neuroprotection, and cancer research. This article uniquely bridges mechanism, protocol, and translational impact—empowering advanced assay decisions.

• Ruthenium Red: Precision Ca2+ Transport Inhibitor for Advanc

  2026-07-23

  Ruthenium Red distinguishes itself as a potent Ca2+ transport inhibitor ideal for dissecting mechanotransduction and autophagy workflows. This guide translates the latest cytoskeleton-dependent autophagy insights into actionable protocols, troubleshooting, and advanced applications—helping researchers achieve reproducible, high-impact results.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-07-23

  Schwartz's dissertation introduces a refined approach for evaluating anti-cancer drug responses in vitro, distinguishing proliferative arrest from cell death using fractional viability metrics. This innovation enhances the interpretability and reliability of preclinical studies, offering new methodological clarity for research on anti-proliferative agents including HDM2 inhibitors.

• Intraarticular Resiniferatoxin for Osteoarthritis Pain Relie

  2026-07-22

  This review highlights intraarticular resiniferatoxin (RTX) as a novel, mechanism-driven analgesic for osteoarthritis pain. The study synthesizes preclinical and early-phase clinical evidence showing that RTX achieves chemical inactivation of TRPV1-positive sensory neurons, offering long-lasting pain relief distinct from conventional treatments.

• DOT1L Inhibition Enhances Innate Immunity in Multiple Myelom

  2026-07-22

  The reference study demonstrates that DOT1L inhibition reprograms innate immune responses and synergistically enhances the efficacy of immunomodulatory drugs in multiple myeloma. These findings identify DOT1L as a central epigenetic vulnerability in MM and elucidate the molecular crosstalk between epigenetic regulation and anti-tumor immunity.

• DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid): Pre

  2026-07-21

  DIDS is a potent anion transport inhibitor targeting chloride channels, notably ClC-Ka and ClC-ec1, with defined IC50 values. Its actions extend to TRPV1 modulation, vasodilation, and tumor suppression, making it a critical tool in physiological and translational research. APExBIO's DIDS (SKU B7675) is supplied for research purposes with rigorously defined properties and benchmarks.

• Resiniferatoxin (RTX): Ultra-Potent TRPV1 Agonist for Analge

  2026-07-21

  Resiniferatoxin (RTX) is a highly selective and ultra-potent TRPV1 agonist with analgesic efficacy 500–1000 times that of capsaicin. RTX induces persistent TRPV1 activation, leading to targeted sensory neuron desensitization and long-lasting pain relief. Its precise mechanism and clinical promise position RTX as a transformative tool in pain research and therapy.

• Dual-Action Inhibition Enhances p38α MAP Kinase Dephosphoryl

  2026-07-20

  The referenced study uncovers how certain kinase inhibitors, including those targeting p38α MAP kinase, not only inhibit kinase activity but also accelerate dephosphorylation by phosphatases. This dual-action mechanism provides new opportunities for designing selective and potent inhibitors for inflammatory disease research.

• Hexamethonium Bromide in Neuronal Signaling Pathway Research

  2026-07-20

  Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic AChRs, unlocks precise manipulation of autonomic ganglia neurotransmission. Researchers can dissect sex-specific mechanisms in hypertension models and optimize protocols for robust, reproducible data.

• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research

  2026-07-19

  Capsazepine empowers translational pain and apoptosis research with precise TRPV1 ion channel antagonism and robust workflow flexibility. Its competitive inhibition of capsaicin binding enables sophisticated dissection of nociception and apoptosis pathways, positioning it as a gold-standard tool for mechanistic studies and drug discovery.

8038 records 4/536 page Previous Next 12345 下5页 Last page